tiprankstipranks
Advertisement
Advertisement

ATRC Stock Latest News

AtriCure reports Q1 EPS ,0c consensus (6c)
The FlyAtriCure reports Q1 EPS ,0c consensus (6c)
15h ago
ATRC
Is ATRC a Buy, Before Earnings?
PremiumPre-Earnings
Is ATRC a Buy, Before Earnings?
3d ago
ATRC
AtriCure initiated with a Buy at Freedom Capital
PremiumThe Fly
AtriCure initiated with a Buy at Freedom Capital
1M ago
ATRC
3 Small-Cap ‘Strong Buy’ Stocks with Big Upside in 2026, According to Analysts
PremiumMarket News
3 Small-Cap ‘Strong Buy’ Stocks with Big Upside in 2026, According to Analysts
2M ago
DEC
ATRC
AtriCure Earnings Call Highlights Growth Amid Headwinds
PremiumCompany Announcements
AtriCure Earnings Call Highlights Growth Amid Headwinds
3M ago
ATRC
AtriCure: Underappreciated Moat, Growing Profitability, and Long-Term Upside in Underpenetrated Cardiac Markets
PremiumRatingsAtriCure: Underappreciated Moat, Growing Profitability, and Long-Term Upside in Underpenetrated Cardiac Markets
3M ago
ATRC
AtriCure price target lowered to $55 from $60 at UBS
Premium
The Fly
AtriCure price target lowered to $55 from $60 at UBS
3M ago
ATRC
AtriCure price target lowered to $53 from $64 at Canaccord
Premium
The Fly
AtriCure price target lowered to $53 from $64 at Canaccord
3M ago
MDT
ATRC
AtriCure: Sustained Outperformance, Manageable Competition, and Undervalued Growth Support Buy Rating and $54 Target
PremiumRatings
AtriCure: Sustained Outperformance, Manageable Competition, and Undervalued Growth Support Buy Rating and $54 Target
3M ago
ATRC
Oppenheimer downgrades AtriCure on new competition from Edwards
PremiumThe Fly
Oppenheimer downgrades AtriCure on new competition from Edwards
3M ago
EW
ATRC
AtriCure downgraded to Perform from Outperform at Oppenheimer
PremiumThe Fly
AtriCure downgraded to Perform from Outperform at Oppenheimer
3M ago
ATRC
AtriCure price target lowered to $52 from $60 at Citizens
PremiumThe Fly
AtriCure price target lowered to $52 from $60 at Citizens
3M ago
ATRC
Closing Bell Movers: Palo Alto Networks down 8% on soft guidance
PremiumThe FlyClosing Bell Movers: Palo Alto Networks down 8% on soft guidance
3M ago
CE
ADI
AtriCure sees FY26 adjusted EPS 0c-4c, consensus (1c)
Premium
The Fly
AtriCure sees FY26 adjusted EPS 0c-4c, consensus (1c)
3M ago
ATRC
AtriCure reports Q4 adjusted EPS 6c, consensus (11c)
Premium
The Fly
AtriCure reports Q4 adjusted EPS 6c, consensus (11c)
3M ago
ATRC
ATRC Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ATRC Earnings this Week: How Will it Perform?
3M ago
ATRC
AtriCure: Sustained Growth and Market Leadership Expected Despite Emerging Competition
PremiumRatings
AtriCure: Sustained Growth and Market Leadership Expected Despite Emerging Competition
3M ago
ATRC
AtriCure: Solid Growth Drivers but Rising Competitive Threat from Edwards Justifies Neutral Stance
PremiumRatings
AtriCure: Solid Growth Drivers but Rising Competitive Threat from Edwards Justifies Neutral Stance
3M ago
ATRC
AtriCure downgraded to Neutral from Overweight at JPMorgan
PremiumThe Fly
AtriCure downgraded to Neutral from Overweight at JPMorgan
3M ago
EW
MDT
AtriCure reports preliminary Q4 revenue $140.5M, consensus $139.29M
PremiumThe FlyAtriCure reports preliminary Q4 revenue $140.5M, consensus $139.29M
4M ago
ATRC
AtriCure sees FY26 revenue $600M-$610M, consensus $598.59M
Premium
The Fly
AtriCure sees FY26 revenue $600M-$610M, consensus $598.59M
4M ago
ATRC
Outset Medical appoints Prange to its board of directors
Premium
The Fly
Outset Medical appoints Prange to its board of directors
4M ago
OM
ATRC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >